Skip To Content Go To Footer

Search for Science, training and resources...

Loading

Please enter at least 3 characters

Create Account Login

Search for Science, training and resources...

Loading

Please enter at least 3 characters

Science Center
Professional Development
Practice Resources
Events
About us
SCIENCE • DIGEST

Create Account Login

Account parameters
Contact Us
Log out

Sign up to our Newsletter

Sign up to receive personalized email communications sent by Cosmétique Active International. They contain offers and news relating to the products and services (such as medical education, invitations to events, quizzes, surveys) concerning L’Oréal Dermatological Beauty brands (including La Roche-Posay, Vichy, CeraVe, SkinCeuticals, SkinAlliance) based on information you may have shared with us and your online browsing activity on this website when you have specifically agreed to this. You can refer to the Privacy policy for more details and unsubscribe at any time through the links in each communication we send.

Home
Epidemiological study of pigmentation disorders and impact on QOL and stigmatisation

Epidemiological study of pigmentation disorders and impact on QOL and stigmatisation
Thierry Passeron, MD, PhD (FR)

Nov 2024
10min

Return To The Replays Page

Related Content

Epidemiological study of pigmentation disorders and impact on QOL and stigmatisation
Nov. 2024
New insights in the physiopathology of hyperpigmentation and clinical impact
Nov. 2024
New topical agent for hyperpigmentation management
Nov. 2024

Professional Development

Continuing Medical Education
Training

Practice Resources

Professional resources
Patient resources

Events

Events Reports

About us

Who are we?
What we care about
Contact us

Our Brands

La Roche-Posay
Vichy
CeraVe
Skinceuticals
SkinAlliance

Settings

Cookie Settings
Terms and Conditions
Privacy Policy